BVF PARTNERS L P/IL Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Latest Insider Trading Transactions of BVF PARTNERS L P/IL

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page: < prev 1 2 3 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Nov 20 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Option Exercise	J	20.00	740	14,800	0
Nov 20 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Option Exercise	J	20.00	93	1,860	0
Nov 20 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Option Exercise	J	20.00	551	11,020	0
Nov 20 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Option Exercise	J	20.00	740	14,800	0
Nov 13 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL		Sell	S	20.19	502,649	10,146,825	81,263	583.9 K to 81.3 K (-86.08 %)
Nov 13 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL		Sell	S	20.19	2,949,477	59,540,207	485,513	3.4 M to 485.5 K (-85.87 %)
Nov 13 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL		Sell	S	20.19	3,941,214	79,560,105	670,695	4.6 M to 670.7 K (-85.46 %)
Nov 03 2020	GLYC	GLYCOMIMETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.75	15,472	42,548	544,363	528.9 K to 544.4 K (+2.93 %)
Nov 03 2020	GLYC	GLYCOMIMETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.75	250,755	689,576	3,206,195	3 M to 3.2 M (+8.48 %)
Nov 03 2020	GLYC	GLYCOMIMETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.75	666,385	1,832,559	4,306,320	3.6 M to 4.3 M (+18.31 %)
Nov 03 2020	GLYC	GLYCOMIMETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.75	15,472	42,548	544,363	528.9 K to 544.4 K (+2.93 %)
Nov 03 2020	GLYC	GLYCOMIMETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.75	250,755	689,576	3,206,195	3 M to 3.2 M (+8.48 %)
Nov 03 2020	GLYC	GLYCOMIMETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.75	666,385	1,832,559	4,306,320	3.6 M to 4.3 M (+18.31 %)
Oct 08 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	5.04	25,107	126,414	566,223	541.1 K to 566.2 K (+4.64 %)
Oct 08 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	5.04	162,352	817,442	3,281,151	3.1 M to 3.3 M (+5.21 %)
Oct 08 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	5.04	157,782	794,432	4,336,875	4.2 M to 4.3 M (+3.78 %)
Sep 24 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.80	32	122	541,116	541.1 K to 541.1 K (+0.01 %)
Sep 23 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.20	7,201	131,057	1,750,704	1.7 M to 1.8 M (+0.41 %)
Sep 23 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.45	4,991	92,062	1,743,503	1.7 M to 1.7 M (+0.29 %)
Sep 23 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.39	10,069	185,120	1,738,512	1.7 M to 1.7 M (+0.58 %)
Sep 23 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.20	9,888	179,960	2,040,124	2 M to 2 M (+0.49 %)
Sep 23 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.45	6,960	128,382	2,030,236	2 M to 2 M (+0.34 %)
Sep 23 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.39	12,259	225,383	2,023,276	2 M to 2 M (+0.61 %)
Sep 17 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.75	10,258	120,532	382,784	372.5 K to 382.8 K (+2.75 %)
Sep 17 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.75	58,745	690,254	2,200,035	2.1 M to 2.2 M (+2.74 %)
Sep 17 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.75	77,751	913,574	2,940,553	2.9 M to 2.9 M (+2.72 %)
Sep 14 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.10	12,816	142,235	372,526	359.7 K to 372.5 K (+3.56 %)
Sep 14 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.10	76,374	847,614	2,141,290	2.1 M to 2.1 M (+3.70 %)
Sep 14 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.10	100,461	1,114,936	2,862,802	2.8 M to 2.9 M (+3.64 %)
Sep 10 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.77	3,830	71,891	1,728,443	1.7 M to 1.7 M (+0.22 %)
Sep 10 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.77	3,907	73,337	2,011,017	2 M to 2 M (+0.19 %)
Sep 08 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.17	14,339	160,167	359,710	345.4 K to 359.7 K (+4.15 %)
Sep 08 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.17	82,740	924,206	2,064,916	2 M to 2.1 M (+4.17 %)
Sep 08 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	11.17	104,827	1,170,918	2,762,341	2.7 M to 2.8 M (+3.94 %)
Sep 01 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.87	7,672	144,741	1,724,613	1.7 M to 1.7 M (+0.45 %)
Sep 01 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.48	6,862	126,814	1,716,941	1.7 M to 1.7 M (+0.40 %)
Sep 01 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.17	922	17,676	1,710,079	1.7 M to 1.7 M (+0.05 %)
Sep 01 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.87	9,900	186,774	2,007,110	2 M to 2 M (+0.50 %)
Sep 01 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	18.48	9,143	168,968	1,997,210	2 M to 2 M (+0.46 %)
Sep 01 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.17	1,122	21,511	1,988,067	2 M to 2 M (+0.06 %)
Aug 25 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.75	2,244	44,308	1,709,157	1.7 M to 1.7 M (+0.13 %)
Aug 25 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.31	5,179	100,003	1,706,913	1.7 M to 1.7 M (+0.30 %)
Aug 25 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.32	1,607	31,050	1,701,734	1.7 M to 1.7 M (+0.09 %)
Aug 25 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.75	3,443	67,982	1,986,945	2 M to 2 M (+0.17 %)
Aug 25 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.31	6,504	125,588	1,983,502	2 M to 2 M (+0.33 %)
Aug 25 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	19.32	9,198	177,720	1,976,998	2 M to 2 M (+0.47 %)
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	180,686	0	0
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	1,000,955	0	0
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	1,336,390	0	0
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	20.00	40,127	802,540	40,127
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Grant	A	20.00	67,791	1,355,820	181,081	113.3 K to 181.1 K (+59.84 %)
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	113,290	0	113,290	0 to 113.3 K
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Grant	A	20.00	389,709	7,794,180	1,017,307	627.6 K to 1 M (+62.10 %)
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	627,598	0	627,598	0 to 627.6 K
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Grant	A	20.00	521,193	10,423,860	1,359,109	837.9 K to 1.4 M (+62.20 %)
Aug 25 2020	KYMR	Kymera Therapeutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	837,916	0	837,916	0 to 837.9 K
Aug 20 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	19.12	1,772	33,881	1,967,800	2 M to 2 M (+0.09 %)
Aug 20 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	19.70	3,496	68,877	1,966,028	2 M to 2 M (+0.18 %)
Aug 20 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	19.27	895	17,246	1,962,532	2 M to 2 M (+0.05 %)
Aug 20 2020	PRNB	Principia Biopharm ...	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	100.00	158	15,800	3,547
Aug 20 2020	PRNB	Principia Biopharm ...	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	100.00	905	90,500	20,390
Aug 20 2020	PRNB	Principia Biopharm ...	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	100.00	1,205	120,500	27,265
Aug 14 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	18.69	21,922	409,810	1,961,637	1.9 M to 2 M (+1.13 %)
Aug 14 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	17.80	1,050	18,693	1,939,715	1.9 M to 1.9 M (+0.05 %)
Aug 14 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	17.34	4,050	70,233	1,938,665	1.9 M to 1.9 M (+0.21 %)
Jul 02 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	13.32	81	1,079	237,475	237.4 K to 237.5 K (+0.03 %)
Jul 02 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	13.32	929	12,371	1,204,981	1.2 M to 1.2 M (+0.08 %)
Jul 02 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	13.32	1,521	20,254	1,667,420	1.7 M to 1.7 M (+0.09 %)
Jun 22 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	13.93	1,354	18,868	237,394	236 K to 237.4 K (+0.57 %)
Jun 22 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	13.93	7,854	109,443	1,204,052	1.2 M to 1.2 M (+0.66 %)
Jun 22 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	13.93	10,524	146,649	1,665,899	1.7 M to 1.7 M (+0.64 %)
Jun 22 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.39	6,769	97,403	236,040	229.3 K to 236 K (+2.95 %)
Jun 22 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.39	39,052	561,939	1,196,198	1.2 M to 1.2 M (+3.37 %)
Jun 22 2020	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.39	52,443	754,629	1,655,375	1.6 M to 1.7 M (+3.27 %)
Jun 10 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.20	6,967	105,898	345,371	338.4 K to 345.4 K (+2.06 %)
Jun 10 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.20	33,321	506,479	1,982,176	1.9 M to 2 M (+1.71 %)
Jun 10 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.20	46,966	713,883	2,657,514	2.6 M to 2.7 M (+1.80 %)
Jun 03 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.00	94,101	1,317,414	338,404	244.3 K to 338.4 K (+38.52 %)
Jun 03 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.00	561,966	7,867,524	1,948,855	1.4 M to 1.9 M (+40.52 %)
Jun 03 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.00	806,443	11,290,202	2,610,548	1.8 M to 2.6 M (+44.70 %)
May 26 2020	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	6.00	192,250	1,153,500	480,432	672.7 K to 480.4 K (-28.58 %)
May 26 2020	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	6.00	1,064,332	6,385,992	2,766,561	3.8 M to 2.8 M (-27.78 %)
May 26 2020	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	6.00	1,027,016	6,162,096	3,712,340	4.7 M to 3.7 M (-21.67 %)
May 18 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.10	4,476	18,352	541,084	536.6 K to 541.1 K (+0.83 %)
May 18 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.10	39,810	163,221	3,118,799	3.1 M to 3.1 M (+1.29 %)
May 18 2020	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.10	249,301	1,022,134	4,179,093	3.9 M to 4.2 M (+6.34 %)
Apr 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Option Exercise	C	13.00	597	7,761	0
Apr 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Option Exercise	C	13.00	656	8,528	0
Apr 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	C	13.00	596,813	7,758,569	1,700,127	1.1 M to 1.7 M (+54.09 %)
Apr 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	C	13.00	655,959	8,527,467	1,934,615	1.3 M to 1.9 M (+51.30 %)
Mar 27 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	17.20	8,264	142,129	1,278,656	1.3 M to 1.3 M (+0.65 %)
Mar 20 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.52	4,439	64,475	1,270,392	1.3 M to 1.3 M (+0.35 %)
Mar 20 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.52	4,439	64,475	1,270,392	1.3 M to 1.3 M (+0.35 %)
Mar 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.73	8,113	127,648	1,265,953	1.3 M to 1.3 M (+0.64 %)
Mar 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.73	10,164	159,916	1,257,840	1.2 M to 1.3 M (+0.81 %)
Mar 17 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	18.34	100,000	1,834,090	1,247,676	1.1 M to 1.2 M (+8.71 %)
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	10,000.00	12	120,000	12
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	10,000.00	87	870,000	191
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	10,000.00	841	8,410,000	1,250
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	10,000.00	981	9,810,000	1,594
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	10,000.00	104	1,040,000	104
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	10,000.00	104	1,040,000	0
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	10,000.00	409	4,090,000	409
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	10,000.00	409	4,090,000	0
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	10,000.00	613	6,130,000	613
Mar 04 2020	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	10,000.00	613	6,130,000	0
Feb 18 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Sell	S	15.79	74,893	1,182,321	424,419	499.3 K to 424.4 K (-15.00 %)
Feb 18 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Sell	S	15.79	510,793	8,063,787	2,350,829	2.9 M to 2.4 M (-17.85 %)
Feb 18 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Sell	S	15.79	486,344	7,677,815	3,131,432	3.6 M to 3.1 M (-13.44 %)
Jan 21 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	16.15	19,727	318,591	244,303	224.6 K to 244.3 K (+8.78 %)
Jan 21 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	16.15	112,561	1,817,860	1,386,889	1.3 M to 1.4 M (+8.83 %)
Jan 21 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	16.15	146,442	2,365,038	1,804,105	1.7 M to 1.8 M (+8.83 %)
Jan 15 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.98	5,406	80,973	224,576	219.2 K to 224.6 K (+2.47 %)
Jan 15 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.98	25,108	376,078	1,274,328	1.2 M to 1.3 M (+2.01 %)
Jan 15 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	14.98	53,448	800,566	1,657,663	1.6 M to 1.7 M (+3.33 %)
Dec 26 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.05	32,606	132,054	536,608	504 K to 536.6 K (+6.47 %)
Dec 26 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.05	201,096	814,439	3,078,989	2.9 M to 3.1 M (+6.99 %)
Dec 26 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.05	281,318	1,139,338	3,929,792	3.6 M to 3.9 M (+7.71 %)
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	22.00	35,888	789,536	0
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	22.00	190,899	4,199,778	0
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Option Exercise	X	22.00	245,481	5,400,582	0
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	22.00	165,961	3,651,142	1,103,314	937.4 K to 1.1 M (+17.71 %)
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	P	22.00	207,234	4,559,148	1,147,676	940.4 K to 1.1 M (+22.04 %)
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	X	22.00	35,888	789,536	159,537	123.6 K to 159.5 K (+29.02 %)
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	X	22.00	190,899	4,199,778	937,353	746.5 K to 937.4 K (+25.57 %)
Dec 20 2019	XOMA	XOMA Corp	BVF PARTNERS L P/IL	10% Owner	Buy	X	22.00	245,481	5,400,582	940,442	695 K to 940.4 K (+35.32 %)
Dec 12 2019	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	9.52	8,506	80,935	499,312	490.8 K to 499.3 K (+1.73 %)
Dec 12 2019	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	9.52	49,804	473,885	2,861,622	2.8 M to 2.9 M (+1.77 %)
Dec 12 2019	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	9.52	60,103	571,880	3,617,776	3.6 M to 3.6 M (+1.69 %)
Dec 12 2019	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	9.40	15,030	141,282	490,806	475.8 K to 490.8 K (+3.16 %)
Dec 12 2019	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	9.40	95,100	893,940	2,811,818	2.7 M to 2.8 M (+3.50 %)
Dec 12 2019	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL	10% Owner	Buy	P	9.40	113,529	1,067,173	3,557,673	3.4 M to 3.6 M (+3.30 %)
Dec 11 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.02	2,397	9,630	504,002	501.6 K to 504 K (+0.48 %)
Dec 11 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.02	18,729	75,244	2,877,893	2.9 M to 2.9 M (+0.66 %)
Dec 11 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.02	113,874	457,489	3,648,474	3.5 M to 3.6 M (+3.22 %)
Nov 26 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.40	81,857	278,322	501,605	419.7 K to 501.6 K (+19.50 %)
Nov 26 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.40	462,056	1,571,037	2,859,164	2.4 M to 2.9 M (+19.28 %)
Nov 26 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.40	576,097	1,958,787	3,534,600	3 M to 3.5 M (+19.47 %)
Nov 18 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.37	11,105	37,424	658,531	647.4 K to 658.5 K (+1.72 %)
Nov 18 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.37	45,888	154,643	3,751,608	3.7 M to 3.8 M (+1.24 %)
Nov 18 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.37	71,495	240,938	4,640,838	4.6 M to 4.6 M (+1.56 %)
Nov 07 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	70,921	283,684	419,748	348.8 K to 419.7 K (+20.33 %)
Nov 07 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	400,470	1,601,880	2,397,108	2 M to 2.4 M (+20.06 %)
Nov 07 2019	FPRX	FIVE PRIME THERAPE ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	496,721	1,986,884	2,958,503	2.5 M to 3 M (+20.18 %)
Oct 31 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.70	57,868	156,244	647,426	589.6 K to 647.4 K (+9.82 %)
Oct 31 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.70	331,048	893,830	3,705,720	3.4 M to 3.7 M (+9.81 %)
Oct 31 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.70	408,592	1,103,198	4,569,343	4.2 M to 4.6 M (+9.82 %)
Oct 31 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.60	116,552	303,035	589,558	473 K to 589.6 K (+24.64 %)
Oct 31 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.60	610,052	1,586,135	3,374,672	2.8 M to 3.4 M (+22.07 %)
Oct 31 2019	CALA	Calithera Bioscien ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.60	872,373	2,268,170	4,160,751	3.3 M to 4.2 M (+26.53 %)

Page: < prev 1 2 3 4 next >